5'-((2,4-dichlorobenzyl)oxy)-5-nitro-[3,3'-bipyridin]-6-amine

ID: ALA4293128

PubChem CID: 145989880

Max Phase: Preclinical

Molecular Formula: C17H12Cl2N4O3

Molecular Weight: 391.21

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncc(-c2cncc(OCc3ccc(Cl)cc3Cl)c2)cc1[N+](=O)[O-]

Standard InChI:  InChI=1S/C17H12Cl2N4O3/c18-13-2-1-10(15(19)5-13)9-26-14-3-11(6-21-8-14)12-4-16(23(24)25)17(20)22-7-12/h1-8H,9H2,(H2,20,22)

Standard InChI Key:  DAJSYFWBEZYECY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   28.9511  -13.2855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9499  -14.1050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6580  -14.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3677  -14.1046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3648  -13.2819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6562  -12.8766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2433  -12.8771    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   31.0710  -12.8707    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   31.0760  -14.5121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7831  -14.1024    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.4914  -14.5098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4881  -15.3255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1956  -15.7329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9036  -15.3231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8997  -14.5017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1916  -14.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6004  -14.0914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3105  -14.4981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0157  -14.0866    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0119  -13.2685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2972  -12.8637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5950  -13.2776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7170  -12.8554    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.2897  -12.0421    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5785  -11.6397    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.9938  -11.6275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  5  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 15 17  1  0
 20 23  1  0
 24 25  2  0
 24 26  1  0
 21 24  1  0
M  CHG  2  24   1  26  -1
M  END

Alternative Forms

  1. Parent:

    ALA4293128

    ---

Associated Targets(Human)

INPPL1 Tchem Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.21Molecular Weight (Monoisotopic): 390.0286AlogP: 4.52#Rotatable Bonds: 5
Polar Surface Area: 104.17Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.43CX LogP: 4.32CX LogD: 4.32
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.51Np Likeness Score: -1.37

References

1. Lim JW, Kim SK, Choi SY, Kim DH, Gadhe CG, Lee HN, Kim HJ, Kim J, Cho SJ, Hwang H, Seong J, Jeong KS, Lee JY, Lim SM, Lee JW, Pae AN..  (2018)  Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's disease.,  157  [PMID:30103190] [10.1016/j.ejmech.2018.07.071]

Source